Evaluation of the Inclisiran Safety in High-Risk Populations

J Am Coll Cardiol. 2024 Apr 2;83(13):e127. doi: 10.1016/j.jacc.2023.12.037. Epub 2024 Mar 25.

Authors

Xin Jiang¹, Zhengjun Zhang¹, Hao Ding²

Affiliations

¹ Baoying People's Hospital, Baoying, Yang-Zhou, Jiangsu Province, China.
² Baoying People's Hospital, Baoying, Yang-Zhou, Jiangsu Province, China; Baoying Maternal and Child Health Hospital, Baoying, Yangzhou, Jiangsu Province, China. Electronic address: dinhao771017@163.com.

PMID: 38538206
DOI: 10.1016/j.jacc.2023.12.037

No abstract available

Publication types

Letter

MeSH terms

Anticholesteremic Agents*
Humans
Hypercholesterolemia*
Proprotein Convertase 9
RNA, Small Interfering

Substances

ALN-PCS
Anticholesteremic Agents
RNA, Small Interfering
Proprotein Convertase 9